This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Nikolaj Skak
Chief Technology Officer at Biograil
Speaker

Profile

Nikolaj Skak is the founding Chief Technology Officer at Biograil, a company developing the BIONDD technology that transforms injectable pharmaceutical products into convenient oral capsules. He is inventor of the BIONND technology and has over 20 years experience in research and development of novel solid oral dosage form technologies in entrepreneurial start-ups and medium sized biotech/pharma.

Agenda Sessions

  • BIONDD – Enabling Oral Administration of Biologics Achieving Drug Exposures Comparable to Injections

    2:30pm